To include your compound in the COVID-19 Resource Center, submit it here.
DISEASE CATEGORY: Autoimmune disease
INDICATION: Multiple sclerosis (MS)
Inhibition of PRL or ZBTB20, a transcription factor
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury